Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Total Liabilities (2019 - 2025)

Cellebrite DI (CLBT) has 6 years of Total Liabilities data on record, last reported at $454.5 million in Q4 2025.

  • For Q4 2025, Total Liabilities rose 28.2% year-over-year to $454.5 million; the TTM value through Dec 2025 reached $454.5 million, up 28.2%, while the annual FY2025 figure was $454.5 million, 28.2% up from the prior year.
  • Total Liabilities reached $454.5 million in Q4 2025 per CLBT's latest filing, up from $354.5 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $498.7 million in Q4 2023 and bottomed at $329.4 million in Q4 2022.
  • Average Total Liabilities over 5 years is $410.1 million, with a median of $413.1 million recorded in 2021.
  • Peak YoY movement for Total Liabilities: skyrocketed 107.21% in 2021, then dropped 28.9% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $413.1 million in 2021, then decreased by 20.26% to $329.4 million in 2022, then soared by 51.38% to $498.7 million in 2023, then decreased by 28.9% to $354.5 million in 2024, then increased by 28.2% to $454.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $454.5 million in Q4 2025, $354.5 million in Q4 2024, and $498.7 million in Q4 2023.